Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis
- PMID: 8409334
- DOI: 10.1016/s0168-8278(05)80245-4
Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis
Erratum in
- J Hepatol 1993 Sep;19(2):325
Abstract
Risk factors for cytomegalovirus and severe bacterial infections were studied prospectively by univariate, multivariate and time-dependent Cox model analysis in 79 consecutive liver transplant patients treated with selective bowel decontamination. Cytomegalovirus infection occurred in 39 patients (49%) and was symptomatic in 22 patients. Twenty-six patients (33%) developed at least one of 43 documented severe bacterial infections. In a multivariate analysis of risk factors for all cytomegalovirus infections, the cytomegalovirus seronegative recipient-cytomegalovirus seropositive donor group was the highest risk group (P < 0.001). Using the same analysis for risk factors for symptomatic cytomegalovirus infections, a prolonged prothrombin time (P < 0.005), a diagnosis of acute fulminant hepatitis as the underlying liver disease (P < 0.01) and a cytomegalovirus seronegative patient receiving a liver from a seropositive donor (P < 0.001) were significant. The treatment with OKT3 therapy (P < 0.008) and hepatic artery thrombosis (P < 0.02) were found to be significant risk factors in a time-dependent univariate analysis but were not independent risk factors when multivariate analysis was utilized. Significant risk factors for major bacterial infections (P < 0.03) using univariate analysis included a prolonged anesthesia, anhepatic and surgical times, as well as the transfusion of large amounts of fresh frozen plasma or autologous blood. In a multivariate analysis, only the transfusion of large amounts of fresh frozen plasma (P < 0.04) was a significant independent risk factor. Cytomegalovirus infection was a risk factor for the development of severe bacterial infections (P < 0.03) in a multivariate time-dependent analysis.
Similar articles
-
OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation.J Infect Dis. 1995 Apr;171(4):1014-8. doi: 10.1093/infdis/171.4.1014. J Infect Dis. 1995. PMID: 7706779
-
Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group.Ann Intern Med. 1997 Feb 15;126(4):275-9. doi: 10.7326/0003-4819-126-4-199702150-00003. Ann Intern Med. 1997. PMID: 9036799 Clinical Trial.
-
Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.Liver Transpl. 2012 Dec;18(12):1448-55. doi: 10.1002/lt.23540. Liver Transpl. 2012. PMID: 22903934
-
Infections following orthotopic liver transplantation.HPB Surg. 1991 Apr;3(4):221-32; discussion 232-3. doi: 10.1155/1991/97375. HPB Surg. 1991. PMID: 1650245 Free PMC article. Review.
-
CMV infection of transplant recipients.J Hepatol. 1996 Aug;25(2):259-69. doi: 10.1016/s0168-8278(96)80083-3. J Hepatol. 1996. PMID: 8878791 Review. No abstract available.
Cited by
-
Management of Antimicrobial Agents in Abdominal Organ Transplant Patients in Intensive Care Unit.Curr Transplant Rep. 2020;7(1):1-11. doi: 10.1007/s40472-020-00268-0. Epub 2020 Jan 24. Curr Transplant Rep. 2020. PMID: 32432022 Free PMC article. Review.
-
Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients.Paediatr Drugs. 2002;4(5):279-90. doi: 10.2165/00128072-200204050-00001. Paediatr Drugs. 2002. PMID: 11994033 Review.
-
Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation.Liver Transpl. 2011 Feb;17(2):149-58. doi: 10.1002/lt.22212. Liver Transpl. 2011. PMID: 21280188 Free PMC article.
-
Atypical presentation of cytomegalovirus infection in a liver transplant patient.J Clin Exp Hepatol. 2011 Dec;1(3):207-9. doi: 10.1016/S0973-6883(11)60236-3. Epub 2012 Jan 2. J Clin Exp Hepatol. 2011. PMID: 25755388 Free PMC article.
-
New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.Clin Microbiol Rev. 2000 Jan;13(1):83-121, table of contents. doi: 10.1128/CMR.13.1.83. Clin Microbiol Rev. 2000. PMID: 10627493 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical